|
1) 日本老年医学会.｢高齢者の終末期の医療およびケア｣に関する日本老年医学会の｢立場表明｣2012.〈https://www.jpn-geriat-soc.or.jp/proposal/pdf/jgs-tachiba2012.pdf〉[Accessed 2021 Aug 31].
|
|
|
|
|
2) Murray SA et al. Illness trajectories and palliative care. BMJ. 2005;330:1007-11.
|
|
|
|
|
3) 日本緩和医療学会(編).終末期がん患者の輸液療法に関するガイドライン2013年版,金原出版,東京.2013.
|
|
|
|
|
|
4) Morita T et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol. 2005;16:640-7.
|
|
|
|
|
|
5) Bruera E et al. Parenteral hydration in patients with advanced cancer:a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013;31:111-8.
|
|
|
|
|
|
6) Yamaguchi T et al. Effect of parenteral hydration therapy based on the Japanese national clinical guideline on quality of life, discomfort, and symptom intensity in patients with advanced cancer. J Pain Symptom Manage. 2012;43:1001-12.
|
|
|
|
|
|
7) Amano K et al. Beliefs and perceptions about parenteral nutrition and hydration by family members of patients with advanced cancer admitted to palliative care units:a nationwide survey of bereaved family members in Japan. J Pain Symptom Manage. 2020;60:355-61.
|
|
|
|
|
|
8) Hui D et al. The last days of life:symptom burden and impact on nutrition and hydration in cancer patients. Curr Opin Support Palliat Care. 2015;9:346-54.
|
|
|
|
|
|
9) Roeland EJ et al. Management of cancer cachexia:ASCO guideline. J Clin Oncol. 2021;38:2438-53.
|
|
|
|
|